Q1 Earnings Estimate for 908 Devices Issued By William Blair

908 Devices Inc. (NASDAQ:MASS) – Stock analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of 908 Devices in a report released on Tuesday, January 14th. William Blair analyst M. Larew expects that the company will post earnings per share of ($0.37) for the quarter. The consensus estimate for 908 Devices’ current full-year earnings is ($1.99) per share. William Blair also issued estimates for 908 Devices’ Q2 2026 earnings at ($0.31) EPS, Q3 2026 earnings at ($0.28) EPS and Q4 2026 earnings at ($0.24) EPS.

Several other equities analysts also recently weighed in on the stock. Leerink Partnrs downgraded shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Leerink Partners reiterated a “market perform” rating and issued a $4.00 price objective (down previously from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Stifel Nicolaus decreased their target price on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Finally, Stephens reaffirmed an “overweight” rating and set a $6.00 price target on shares of 908 Devices in a research report on Wednesday.

908 Devices Stock Performance

MASS opened at $2.91 on Thursday. 908 Devices has a 52-week low of $1.81 and a 52-week high of $8.50. The firm’s 50-day moving average price is $2.41 and its 200-day moving average price is $3.53.

Institutional Trading of 908 Devices

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MASS. SG Americas Securities LLC acquired a new position in shares of 908 Devices in the third quarter worth about $36,000. B. Riley Wealth Advisors Inc. purchased a new position in 908 Devices during the third quarter worth approximately $45,000. Drive Wealth Management LLC purchased a new position in shares of 908 Devices during the 3rd quarter valued at approximately $50,000. Townsquare Capital LLC purchased a new position in 908 Devices in the 3rd quarter valued at about $50,000. Finally, 49 Wealth Management LLC lifted its position in shares of 908 Devices by 16.2% in the third quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after acquiring an additional 4,343 shares in the last quarter. Institutional investors and hedge funds own 88.06% of the company’s stock.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.